on 19 May 2021
Last Applicant/ Owned by
Tris Pharma, Inc.
2031 US Highway 130
Monmouth Junction, New Jersey, 08852
Serial Number
UK00003643856 filed on 19th May 2021
Registration Number
UK00003643856 registered on
31st Dec 1969
Correspondent Address
One London Wall
London,
EC2Y 5EB
Pharmaceutical preparations, namely, beta-Hydroxy beta-methylglutaryl-CoA (HMG-CoA) reductase inhibitors used to lower LDL cholesterol and to treat hypertriglyceridemia as an adjunct to diet, cholesterol lowering medications; pharmaceutical preparations that act as central nervous system stimulants; pharmaceutical preparations, namely, neuromodulators for treatment of psychiatric disorders and disorders related to attention-deficit hyperactivity disorder; pharmaceutical preparations for the treatment of attention-deficit hyperactivity disorder (ADHD); liquid oral pharmaceutical preparations for the treatment of attention-deficit hyperactivity disorder (ADHD); solid pharmaceutical preparations for the treatment of attention-deficit hyperactivity disorder (ADHD); pharmaceutical preparations for the treatment of narcolepsy; pharmaceutical preparations for the treatment of chronic lung disease; pharmaceutical preparations for the treatment of colds; pharmaceutical preparations for the treatment of coughs; extended release liquid for the treatment of coughs; pharmaceutical preparations for the treatment of upper respiratory symptoms; pharmaceutical preparations for the treatment of pain.
Scientific research and development for pharmaceuticals, neutraceuticals, drug delivery products and biomedical products and raw materials and components used in pharmaceuticals; testing for others of pharmaceuticals, neutraceuticals, drug delivery products and biomedical products.
UK00003643856
Figurative
Individual